Advertisement

Topics

Mylan: Reinspection of Biocon plant brings biosimilar confidence

05:46 EST 1 Dec 2017 | BioPharma-Reporter

The EMA has accepted to review Mylanâs trastuzumab and pegfilgrastim biosimilars amid remediation efforts at biomanufacturing partner Bioconâs fill and finish plant in India.

Original Article: Mylan: Reinspection of Biocon plant brings biosimilar confidence

NEXT ARTICLE

More From BioPortfolio on "Mylan: Reinspection of Biocon plant brings biosimilar confidence"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...